Cartography Biosciences, Inc.

About Cartography Biosciences, Inc.

Cartography Biosciences is an oncology company focused on advancing precision cancer therapeutics by designing cancer immunotherapies around the safest and most effective targets. Their mission is to widen the world of treatable cancers through smarter target identification using a comprehensive antigen atlas, bridging immunology and computation to create therapies that are precise, effective, and safe.

Products & Services

Cancer Immunotherapies:Developing precision immunotherapies designed to target tumor cells specifically, using a range of modalities to minimize toxic side effects and maximize effectiveness.

Antigen Atlas Platform:A novel approach to target identification for cancer therapies, analyzing antigen expression across patient samples and millions of cells using single-cell genomics, proteomics, and binder discovery methods.

Specialties

Cancer Immunotherapies Precision Oncology Antigen Target Identification Single-Cell Genomics Proteomics Computational Immunology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 67000000 MR: - FA: 67 million FAN: 67000000	D: 2025-10-02 FD: 2025-10-02	13 investors

Series B Latest

2025-10-02

$67.0M

13 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Annie Winterhall

Head of Clinical Operations

C

Chester Wong

SVP of Business Development

D

Dan Rock, Ph.D

CSO

D

David Kugler, Ph.D.

VP/Research and Early Development

D

Dirk Nagorsen

Chief Medical Officer

E

Erin Daruszka

Head of People

View 54 more team members with Pro

Unlock Full Team Directory

Recent News